Encantados de anunciar que Viromii está participando en el proyecto Bioreact, financiado por la Agencia Valenciana de la Innovación (AVI). […]
Category: Insights
Divulgation: a fundamental support for innovation
Innovation can be defined in many ways; it is a broad concept. In general, people think about innovation as finding […]
2020 at Viromii, what a year!
What a strange year! At Viromii we wanted to share our evolution now that we are facing the end of […]
Activity update during the COVID19 lockdown
Finally, after more than 3 months working remotely, we are back at the office! Of course, keeping all the safety […]
Theranostics – An innovative approach against cancer.
During the past months, at Viromii we have been working with some innovative cancer therapies. Concretely, we have been working […]
Thanks for this amazing 2019!
An entire year has passed, and from Viromii we can say that it has been really exciting and we have […]
Glucose monitoring – A vibrant area with a promising future
Recently, at Viromii we have been working with a new type of sensor for glucose monitoring. Specifically, we are performing […]
Biohub VLC – a first step for consolidating Valencia as a Biotech Hub?
In one of the most privileged environments of the city of Valencia, also qualified as the pole of innovation and […]
The 4 steps of our market validation analysis
As all of you know, we develop services for supporting technology transfer operations in research-based institutions such as universities and […]
Viromii has already been one year around !
More or less one year ago, we came back to Spain from Sweden with the idea of setting up a […]
Phage therapy, the solution for multiresistant bacteria?
Recently, at Viromii, we have been working on a really interesting project regarding phage therapy, a promising area that can help […]
Innovative strategies for extending drugs’ market exclusivity.
In the previous post, we explored the different preventive strategies pharma companies use to maintain their market exclusivity. At Viromii we feel this […]
SME Phase 1, one last call and a long-lasting impact in almost 4000 Start-ups.
For some time at Viromii we have been developing a tool that facilitates technology transfer activities by helping experts identify […]
Preventive strategies for extending drugs’ market exclusivity in US and EU.
In the previous post we could see the greatly negative impact that losing market exclusivity has over the financials of pharmaceutical companies, […]
When pharma companies lose control and exclusivity over a blockbuster.
Lately, at Viromii, we have been working with some really interesting projects in the pharma industry, this has made us […]
Guidelines for creating a TTO, what do you have to bear in mind before taking the step?
In the previous post, we explained the impact of the teacher’s exemption over university’s technology transfer performance. However, in this […]
Professor’s privilege, does it really impact technology transfer?
Universities are the cradle of knowledge, new technologies and innovation. These new technologies and innovations can be the base for […]
Which are the most important performance parameters in ventures and startups?
We, at Viromii. have asked this question to many actors within the european startup ecosystem, and found interesting insights that […]